Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2006-11-07
2006-11-07
Sullivan, Daniel M. (Department: 1636)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S029000, C435S352000, C435S363000
Reexamination Certificate
active
07132287
ABSTRACT:
The present invention relates to a method for differentiating a neural stem cell into a neuronal cell such as a neuroblast or a neuron in vitro or in vivo. Particularly, the invention provides for a method for neural stem cell differentiation by contacting the neural stem cell with a 5HT1A ligand or agonist.
REFERENCES:
patent: 5753506 (1998-05-01), Johe et al.
patent: 5766948 (1998-06-01), Gage et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 6103530 (2000-08-01), Carpenter et al.
patent: 6149902 (2000-11-01), Artavanis-Tsakonas et al.
patent: 97/08159 (1997-03-01), None
patent: 00/16777 (2000-03-01), None
patent: 01/34586 (2001-05-01), None
Mattson MP. Stem cells as therapeutics for neurodegenerative disorders? Exp. Rev. Neurotherap. (2001), 1(2), 267-273.
Kordower et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med. Apr. 27, 1995;332(17):1118-24.
Freeman et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol. Sep. 1995;38(3):379-88.
Widner et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med. Nov. 26, 1992;327(22):1556-63.
Barker et al. Neural transplantation therapies for Parkinson's and Huntington's diseases. Drug Discov Today. Jun. 1, 2001;6(11):575-582.
Lindvall et al. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med. Jul. 2004;10 Suppl:S42-50.
Isacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol. Jul. 2003;2(7):417-24.
Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science. Feb. 25, 2000;287(5457):1442-6.
Protais et al. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Eur J Pharmacol. Jul. 10, 1998;352(2-3):179-87.
Zhou et al. Mechanisms governing the differentiation of a serotonergic phenotype in culture. Brain Res. Sep. 15, 2000;877(1):37-46.
Vicario-Abejon et al. Hippocampal stem cells differentiate into excitatory and inhibitory neurons. Eur J Neurosci. Feb. 2000;12(2):677-88.
Buznikov et al., “Serotonin and Serotonin-Like Substances as Regulators of Early Embryogenesis and Morphogenesis,”Cell Tissue Res., Aug. 2001, vol. 305, No. 2, pp. 177-186.
Chumasov et al., “Effect of Serotonin on Growth and Differentiation of Hippocampal Cells in Culture,”Neurosci. Behav. Physiol., Mar. 1980, vol. 10, No. 2, pp. 125-131.
Chubakov et al., “Effect of Serotonin on the Development of a Rat Cerebral Cortex Tissue Culture,”Neurosci. Behav. Physiol., Nov. 1986, vol. 16, No. 6, pp. 490-497.
Chubakov et al., “Effect of Serotonin on the Morpho-Functional Development of a Rat Cerebral Neocortex in Tissue Culture,”Brain Res., Mar. 1986, vol. 369, pp. 285-297.
Abe, “Therapeutic Potential of Neurotrophic Factors and Neural Stem Cells Against Ischemic Brain Injury,”Cereb. Blood Flow Metab., Oct. 2000, vol. 20, No. 10, pp. 1393-1408.
Ourednik et al., “Neural Stem Cells—A Versatile Tool for Cell Replacement and Gene Therapy in the Central Nervous System,”Clin. Genet., Oct. 1999, vol. 56, No. 4, pp. 267-278.
Lieske et al., “Effects of Serotonin on Neurite Outgrowth from Thalamic NeuronsIn Vitro,” Neuroscience, Mar. 1999, vol. 90, No. 3, pp. 967-974.
Semkova et al., “Neuroprotective Effect of 5-HT1AReceptor Agonist, Bay X 3702, Demonstrated In Virto and In Vivo,”Eur. J. Pharmacol, Oct. 1998, vol. 359, pp. 251-260.
Shetty and Turner, J Neurobiol. 1998;35:395-425.
Caldwell et al., Nat Biotechnol. 2001;19:475 9.
Mahlberg, et al., J Neurosci. 2000;20:9104-10.
Yocca, J Clin Psychipharmacology 1990;10(suppl., 3):6S-12S.
Durig et al., Dev Neurosci 2000; 11:833-837.
Lavdas et al., J Neurosci 1997; 17:7872-7880.
Jacobs et al., Mol Psychiatry 2000; 4:262-69.
Schuldiner et al., Brain Res 2001; 913:201-205.
Altar C. Anthony
Rajan Prithi
Psychiatric Genomics, Inc.
Sullivan Daniel M.
LandOfFree
Method for neural stem cell differentiation using 5HT-1A... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for neural stem cell differentiation using 5HT-1A..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for neural stem cell differentiation using 5HT-1A... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3679950